# Exenatide for Treating Cocaine Use Disorder

> **NCT04941521** · PHASE1,PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 3 (actual)

## Conditions studied

- Cocaine Use Disorder

## Interventions

- **DRUG:** Exenatide 2 mg [Bydureon]
- **BEHAVIORAL:** Drug Counseling

## Key facts

- **NCT ID:** NCT04941521
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-24
- **Primary completion:** 2021-11-17
- **Final completion:** 2021-11-17
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2022-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04941521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04941521, "Exenatide for Treating Cocaine Use Disorder". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04941521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*